1,362,000 doses of pediatric vaccines arrive in Spain

Deepak Gupta December 13, 2021
Updated 2021/12/13 at 11:00 AM

The first consignment of pediatric vaccines, Comirnaty (Pfizer / BioNTech) destined for a population between 5 and 11 years old, made up of 1,362,000 doses are already in Spain, as reported this Monday by the Ministry of Health.

This first consignment will be distributed according to target population criteria among all autonomous communities and cities. Vaccination against Covid-19 in children aged 5 to 11 years will begin on December 15 throughout Spain, in the places established by the autonomous communities and cities for it.

Health recalls that “vaccination of the population between 5 and 11 years of age is recommended, preferably starting with high-risk people and the oldest cohorts (10 and 11 years)” and that this vaccine has shown efficacy against Covid-19 symptomatic of 90.7% in clinical trials with boys and girls between 5 and 11 years, with a lower reactogenicity than in the group of 16 to 25 years.

The vaccine to be administered will be the pediatric presentation of the Comirnaty vaccine. The interval between doses will be at least 8 weeks to achieve a better immune response and a better safety profile, highlighted the Ministry directed by Carolina Darias.

As in adults, after receiving the vaccination, minors should be observed for 15 minutes to detect immediate reactions. In people with a history of a severe allergic reaction, regardless of the cause, a follow-up will be maintained up to 30 minutes after vaccination.

Children between 5 and 11 years of age with a history of SARS-CoV-2 infection, regardless of the confirmation date, will be vaccinated as follows: with a single dose starting four weeks after diagnosis of the infection or symptom onset date. In the case of having an infection after having received the first dose, the regimen will be completed with a second dose after recovery and when four weeks have elapsed after the infection, also maintaining the eight-week interval with respect to the first dose.

Print Friendly, PDF & Email
Share this Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *